Related Experiment Videos
Efficacy and acceptability of different dosage schedules of clonidine
Insights
Clonidine dosing frequency impacts hypertension control. Thrice-daily dosing offered better blood pressure management than once-daily, though patients preferred once-daily for reduced drowsiness. Twice-daily dosing may balance efficacy and convenience.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Clinical Pharmacy
Background:
- Hypertension management requires optimal medication dosing for efficacy and patient adherence.
- Clonidine is an antihypertensive agent whose dosing schedule may influence its effectiveness and side effect profile.
Purpose of the Study:
- To compare the efficacy of different clonidine dosing regimens (once, twice, and thrice daily) in hospitalized hypertensive patients.
- To assess patient preference and tolerability concerning various clonidine administration schedules.
Main Methods:
- A study involving 12 hospitalized patients with hypertension.
- Comparison of blood pressure control with clonidine administered once daily (8 P.M.), twice daily, and thrice daily.
- Assessment of patient-reported drowsiness and overall preference for each dosing regimen.
Main Results:
- Thrice-daily clonidine provided superior blood pressure control compared to a single daily dose.
- The single daily 8 P.M. dose resulted in wider blood pressure fluctuations and inadequate control 18 hours post-administration.
- Ten out of 12 patients preferred the once-daily regimen due to lack of daytime drowsiness, despite less consistent blood pressure control.
Conclusions:
- Twice-daily clonidine administration, with a larger dose at bedtime and a smaller morning dose, may offer an optimal balance.
- This optimized twice-daily regimen could enhance blood pressure control, reduce unwanted drowsiness, and improve dosing convenience.
- Individualized clonidine dosing strategies are crucial for effective hypertension management.
Abstract:
In 12 hospitalized patients with hypertension, clonidine 3 times a day led to better control of blood pressure than did the same total dose administered once daily. Compared to the uniform control of blood pressure on divided dose regimen, the single daily 8 P.M. dose led to wider fluctuations and inadequate control 18 hr after dosing. However, 10 of the 12 patients preferred the single daily dose at 8:00 P.M. to the divided dose regimen because of no drowsiness during the day. In 2 patients administration of clonidine twice daily resulted in better control of blood pressure than that during the single or thrice-daily dose regimens. Since there appeared to be a correlation between the dose and the duration of adequate blood pressure control, administration of clonidine twice a day with a larger dose at bedtime and a smaller dose before noon could limit unwanted drowsiness and combine the convenience of less frequent dosing with superior blood pressure control.